Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks
Boehringer-Ingelheim has been ordered to pay $1.25 million to the family of a woman who died of Pradaxa gastrointestinal bleeding side effects.…
«
»
Boehringer-Ingelheim has been ordered to pay $1.25 million to the family of a woman who died of Pradaxa gastrointestinal bleeding side effects.…
A Jardiance lawsuit claims that the diabetes drug caused an Arizona woman to suffer diabetic ketoacidosis after less than two months of use.…
A Jardiance ketoacidosis lawsuit has been cleared to proceed after a federal judge denied a motion to have the case dismissed by the drug’s manufacturers…
A number of diabetes drug manufacturers have been named in a wrongful death lawsuit indicating that drugs like Invokana, Farxiga and Jardiance caused a Kentucky man to die of respiratory failure and kidney failure.…
A wrongful death lawsuit will proceed against Pradaxa after a federal judge rejected efforts by the manufacturer to have the case dismissed.…
A new lawsuit indicates the use of Invokana and Jardiance diabetes drugs caused a woman to suffer diabetic ketoacidosis, which left her hospitalized for days.…
A reversal agent for the blood thinner Pradaxa is now available nationwide after thousands of bleeding events and lawsuits.…
Studies presented this week both claim that Pradaxa and Eliquis cause less major bleeding events than warfarin, amid continuing injury lawsuits filed by users of the new-generation anticoagulants.…
A new study lambasts the FDA’s decisions to approve and defend the blood thinner Pradaxa, saying it has likely killed thousands and that the FDA was too permissive to its manufacturer.…
The FDA has approved a reversal agent for the blood thinner Pradaxa called Praxbind, which is supposed to stop the drug’s blood thinning effects in patients suffering a bleeding emergency.…